Prenetics Global Ltd
PRENW0.033USD
+0.000+0.31%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de Prenetics Global Ltd Compañía
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Información de la empresa
Símbolo de cotizaciónPRENW
Nombre de la empresaPrenetics Global Ltd
Fecha de salida a bolsaJul 06, 2021
Director ejecutivoMr. Joel Neoh
Número de empleados- -
Tipo de seguridadCompany Warrant
Fin del año fiscal- -
DirecciónUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
Ciudad
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísHong Kong
Código postal- -
Teléfono85222109588
Sitio Webhttps://ir.prenetics.com/
Símbolo de cotizaciónPRENW
Fecha de salida a bolsaJul 06, 2021
Director ejecutivoMr. Joel Neoh
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andy Cheung
Mr. Andy Cheung
Director
Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alan Thomas
Mr. Alan Thomas
Vice President, Supply Chain & Operations
Vice President, Supply Chain & Operations
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Ms. Samantha Kwok
Ms. Samantha Kwok
Chief of Staff to Group Chief Executive Officer, Vice President - People and Operations
Chief of Staff to Group Chief Executive Officer, Vice President - People and Operations
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andy Cheung
Mr. Andy Cheung
Director
Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alan Thomas
Mr. Alan Thomas
Vice President, Supply Chain & Operations
Vice President, Supply Chain & Operations
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 2 de jul
Actualizado: mié., 2 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Other
100.00%
Accionistas
Accionistas
Proporción
Other
100.00%
Tipos de accionistas
Accionistas
Proporción
Other
100.00%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
30
3.30M
0.00%
-1.79M
2025Q1
31
3.30M
0.00%
-1.97M
2024Q4
34
4.00M
0.00%
-742.40K
2024Q3
37
3.17M
0.00%
-3.22M
2024Q2
39
4.52M
0.00%
-1.61M
2024Q1
39
4.73M
0.00%
-1.56M
2023Q4
39
5.08M
0.00%
-1.26M
2023Q3
38
5.18M
0.00%
-1.17M
2023Q2
36
5.20M
0.00%
-1.29M
2023Q1
36
5.53M
0.00%
-1.11M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
LMR Partners LLP
1.30M
0%
--
--
Mar 31, 2025
Aspex Management (HK) Limited
1.17M
0%
--
--
Mar 31, 2025
Citadel Advisors LLC
12.77K
0%
-301.52K
-95.94%
Mar 31, 2025
Calamos Advisors LLC
200.00K
0%
--
--
Mar 31, 2025
Walleye Capital LLC
160.29K
0%
-35.53K
-18.15%
Mar 31, 2025
D. E. Shaw & Co., L.P.
104.52K
0%
--
--
Mar 31, 2025
Jane Street Capital, L.L.C.
82.65K
0%
--
--
Mar 31, 2025
Peak6 Capital Management LLC
66.67K
0%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
